Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
about
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasiaModifying Risk Factors in the Management of Erectile Dysfunction: A ReviewTranslational Research and Functional Changes in Voiding Function in Older AdultsEjaculatory dysfunction in the treatment of lower urinary tract symptomsEvidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasiaTowards engineering hormone-binding globulins as drug delivery agentsIntegrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies.Insulin Resistance Is Associated with Prevalence of Physician-Diagnosed Urinary Incontinence in Postmenopausal Non-Diabetic Adult Women: Data from the Fourth Korea National Health and Nutrition Examination Survey.Nitric Oxide Synthase is Necessary for Normal Urogenital DevelopmentAlpha-blocker use is associated with decreased risk of sexual dysfunction.Effects of testosterone on the lower urinary tract go beyond the prostate: New insights, new treatment options.Benign prostatic hyperplasia: from bench to clinicMetabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.Late-onset hypogonadism syndrome and lower urinary tract symptoms.Heart Rate Variability: A Risk Factor for Female Sexual Dysfunction.Cardiovascular Risk Factors and Ethnicity Are Independent Factors Associated with Lower Urinary Tract SymptomsTestosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling.Protective Effects of KH-204 in the Bladder of Androgen-Deprived Rats.Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.Metabolic syndrome is predictive of lower urinary tract symptom improvement after holmium laser enucleation of the prostate for benign prostatic obstruction.Impact of medical treatments for benign prostatic hyperplasia on sexual function.Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?Interaction between interstitial cells and smooth muscles in the lower urinary tract and penis.Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-upLower urinary-tract symptoms and testosterone in elderly menAndrogens and male aging: Current evidence of safety and efficacy.Epinephrine is associated with both erectile dysfunction and lower urinary tract symptomsLower urinary tract symptoms and sexual dysfunction: a common approach.Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations.The effect of Bongardia Chrysogonum on prostate tissue in a rat model of STZ-induced diabetes.Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.Voiding dysfunction in men: pathophysiology and risk factors.Erectile function and late-onset hypogonadism symptoms related to lower urinary tract symptom severity in elderly men.Measurement of benign prostatic hyperplasia treatment effects on male sexual function.Preliminary assessment of Neck Circumference in Benign Prostatic Hyperplasia in Patients with Metabolic SyndromeEndothelial dysfunction and erectile dysfunction in the aging man.Sexuality and elderly with chronic diseases: A review of the existing literature.Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action.Urological aspects of the metabolic syndrome.
P2860
Q24199135-981999FE-9CB2-436A-B631-B3D24F20D5F6Q26737722-91773CBC-3E3E-4775-B610-52BE997585B0Q26782134-6953108C-CBB7-45F9-B1F4-8232B1ED489FQ28073775-CE62476F-79F1-460C-AADC-9E8C87608CD8Q28077954-C930F9CA-FBFD-48E3-A48D-9904CA841909Q28545213-9465591B-33AA-4FC3-A04D-382E7825D3E7Q30373008-B8E25DA2-5CB6-4AD0-ABE6-CEF05114AFD2Q31015734-75FD913D-8140-4D4C-9FF2-C671477E988AQ33699907-66FB1823-5EF8-4A34-BECB-E9B166031CEDQ33822420-66467E27-CAB9-4AA7-B513-CEFF753776A4Q34114694-F2B0041C-6433-4F71-82F5-88ECA9057C0FQ34216723-CB955B97-A0CF-48F0-A1BC-FE94C108E179Q35182377-1AC681BC-674B-4AA1-BB68-2E0A507F775AQ35539874-5D1ACAF8-40E4-4558-8750-BF449538C04CQ35665299-4576C4FF-FF68-433C-A506-8E8A35664A2CQ35670790-928688DD-E390-4C3C-AF99-DAC868F568EAQ35924409-B0786ABA-603B-4787-9F8C-69C2B9563D26Q35998591-59CFA01B-7714-42D9-9834-DF1753575B85Q36000844-240E34FD-B532-4B52-8052-1C6B24DBFBCAQ36080363-B4811BFE-8E21-4883-A7B9-884B29E0AAE1Q36329234-5CAFC94E-3F56-4761-B2E2-FE4ABA656DC3Q36409144-4210CBAC-C472-46F5-86E4-2933B281B4C3Q36409148-6B2CF57D-5B96-4A05-A851-791C2351A2F7Q36583134-EEB14E2C-D59F-4662-A647-1D72DF496790Q36805920-527A1E28-0CEA-4536-BD06-B0207F10F240Q36839032-F5A2496A-CDB8-4B89-9560-802F3F9954D3Q37084126-09FF2354-CF5A-4E52-8EA8-AA59CFFEEDBFQ37092203-D4CA5025-216B-4861-AF39-573942660987Q37097048-54C7E639-59E3-4F23-9B57-CB1CE74D49EBQ37103371-D8E42F06-9B44-4269-A467-EFAA10C02844Q37167114-48B6064F-F4DA-40CB-A886-45A037AA7F56Q37192948-ABA1FA0F-2F24-4682-A946-51BA3767D5DDQ37323306-22790576-9025-48DB-8942-304826E3FDB5Q37370480-D9495482-28BF-4006-9455-4BB29CC73907Q37523227-248F5D6B-6C32-47A6-BA26-6DAE7D69490BQ37626508-41F51662-39F0-4C37-B5A6-C3C6DDF02EF2Q37650850-05838782-BF50-4A2E-A7FA-1D4401066D3CQ37697909-B2B24402-9468-4BBB-B4EF-2D5986C25F75Q37833959-D7F50587-86CC-4703-9588-0F467C57B8B5Q37910709-1699FE08-8A19-4FA4-B4AF-77E7D65DF316
P2860
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
@ast
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
@en
type
label
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
@ast
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
@en
prefLabel
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
@ast
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
@en
P2860
P1433
P1476
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
@en
P2093
Kevin McVary
P2860
P304
23-8; discussion 44-5
P356
10.1111/J.1464-410X.2006.06102.X
P478
97 Suppl 2
P577
2006-04-01T00:00:00Z